Table 5.
Correlation between ISQEut and BIC, and between ISQEut and BAT for each implant system (surface) and time (group).
| G1: 2 Weeks | G2: 4 Weeks | G3: 8 Weeks | G1: 2 Weeks | G2: 4 Weeks | G3: 8 Weeks | ||
|---|---|---|---|---|---|---|---|
| Surface | ISQ Eut vs. BIC (%) | ISQ Eut vs. BAT (%) | |||||
| SLA® | Spearman’s rho | 0.828 | 0.943 | 0.000 | 0.828 | 0.894 | −0.621 |
| p | 0.052 | 0.057 | 1.000 | 0.052 | 0.106 | 0.188 | |
| N | 6 | 4 | 6 | 6 | 4 | 6 | |
| SLActive® | Spearman’s rho | 0.683 | 0.956 | −0.146 | 0.634 | −0.598 | −0.537 |
| p | 0.062 | 0.053 | 0.729 | 0.091 | 0.210 | 0.170 | |
| N | 8 | 6 | 8 | 8 | 6 | 8 | |
| ContacTi® | Spearman’s rho | −0.717 | −0.206 | 0.244 | −0.478 | −0.466 | −0.098 |
| p | 0.109 | 0.625 | 0.560 | 0.338 | 0.245 | 0.818 | |
| N | 6 | 8 | 8 | 6 | 8 | 8 | |